These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21423309)

  • 1. [Cannabis and urine samples].
    Westin AA
    Tidsskr Nor Laegeforen; 2011 Mar; 131(6):577-80. PubMed ID: 21423309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary excretion of cannabis metabolites].
    Kielland KB
    Tidsskr Nor Laegeforen; 1992 May; 112(12):1585-6. PubMed ID: 1615510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson EK; Hollister LE; Halldin MM
    NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest of adjusting urine cannabinoids to creatinine level to monitor cannabis cessation therapy in heavy smokers with psychiatric disorders.
    Duflot T; Vasse M; Guillerme J; Schrapp A; Mory C; Imbert L; Djerada Z; Protais Y; Guillin O; Goetz H; Lamoureux F
    Drug Test Anal; 2019 Sep; 11(9):1453-1459. PubMed ID: 31261442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Passive exposure in detection of low blood and urine cannabinoid concentrations].
    Skopp G; Pötsch L
    Arch Kriminol; 2001; 207(5-6):137-47. PubMed ID: 11508050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
    Pacifici R; Pichini S; Pellegrini M; Tittarelli R; Pantano F; Mannocchi G; Rotolo MC; Busardò FP
    Clin Chem Lab Med; 2018 Dec; 57(2):238-243. PubMed ID: 30332386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Passive inhalation of cannabis smoke--is it detectable?].
    Westin AA; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):109-13. PubMed ID: 19151803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of cannabinoids in urine].
    Kataev SS; Zelenina NB; Melent'ev AB; Zalesova VA; Kurdina LN
    Sud Med Ekspert; 2005; 48(2):35-8. PubMed ID: 15881141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative high performance thin layer chromatography (HPTLC) analysis of cannabinoids in urine samples of Cannabis abusers.
    Sharma P; Bharath MM; Murthy P
    Indian J Med Res; 2010 Aug; 132():201-8. PubMed ID: 20716821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of cannabis in the urine. Demonstrations in an institution for drug addicts].
    Høglend P; Kielland KB
    Tidsskr Nor Laegeforen; 1983 Aug; 103(24):1691-3. PubMed ID: 6605596
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of thin-layer chromatography for detection of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in the urine].
    Nikonova EV; Karaeva LD
    Sud Med Ekspert; 2005; 48(5):33-5. PubMed ID: 16279498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrocannabinols in clinical and forensic toxicology.
    Kochanowski M; Kała M
    Przegl Lek; 2005; 62(6):576-80. PubMed ID: 16225128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cannabigerol and its presumptive metabolite in human urine after Cannabis consumption.
    Hidvégi E; Somogyi GP
    Pharmazie; 2010 Jun; 65(6):408-11. PubMed ID: 20614687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.
    Musshoff F; Madea B
    Ther Drug Monit; 2006 Apr; 28(2):155-63. PubMed ID: 16628124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
    Beardsley GD; Christensen JM
    Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and disposition of cannabinoids.
    Chiang CN; Rapaka RS
    NIDA Res Monogr; 1987; 79():173-88. PubMed ID: 2830536
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies of drug detection using recent immunologic methods].
    Käferstein H; Sticht G
    Beitr Gerichtl Med; 1990; 48():51-6. PubMed ID: 2241837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the prevalence of cannabinoid use urine testing: a preliminary study in Kerman, Iran.
    Meimandi MS; Nakhaee N; Divsalar K; Dabiri S
    Addict Behav; 2005 Aug; 30(7):1464-7. PubMed ID: 16022943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Δ9-tetrahydrocannabinol in exhaled breath collected from cannabis users.
    Beck O; Sandqvist S; Dubbelboer I; Franck J
    J Anal Toxicol; 2011 Oct; 35(8):541-4. PubMed ID: 22004672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.